Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Velcade for Proliferative Lupus Nephritis
NCT01169857Phase 4Withdrawn
- Sponsor
- Rogosin Institute
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of bortezomib in lupus nephritis (LN), sponsored by Rogosin Institute. Planned start Aug 2010; status: withdrawn.
02
Drugs
bortezomib
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT01169857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169857.